Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Molecular Cancer|September 24, 2010
Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGEStephanie M Pütz, Fotini Vogiatzi, Thorsten Stiewe, et al.Nature Communications|June 4, 2014
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferasesJoël P Charles, Jeannette Fuchs, Mirjam Hefter, et al.Journal of Clinical Medicine|July 2, 2021
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In VivoDorothee Winterberg, Lennart Lenk, Maren Oßwald, et al.Molecular Cell|May 18, 2010
DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosisKatharina Schlereth, Rasa Beinoraviciute-Kellner, Marie K Zeitlinger, et al.Blood|July 13, 2017
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenograftsDenis M Schewe, Ameera Alsadeq, Cornelia Sattler, et al.Frontiers in Immunology|September 2, 2022
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumabNiklas Baumann, Christian Arndt, Judith Petersen, et al.Hemasphere|March 4, 2024
Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockadeDenis M Schewe, Fotini Vogiatzi, Ira A Münnich, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5Fotini Vogiatzi, Dominique T Brandt, Jean Schneikert, et al.Nature Communications|June 26, 2020
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemiaHend Abdelrasoul, Anila Vadakumchery, Markus Werner, et al.Leukemia|November 21, 2022
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)Sophie Steinhäuser, Patricia Silva, Lennart Lenk, et al.Pageof 2